Literature DB >> 3500826

Natural course and prognosis of HLA-B27-positive oligoarthritis.

M Schattenkirchner1, K Krüger.   

Abstract

A long-term follow-up of 119 patients with the descriptive diagnosis of B27-positive oligoarthritis showed that after a time between months to several years about half of the patients with this condition develop a definite disease of the seronegative spondarthritis group, especially ankylosing spondylitis. Another great part of the patients go into a complete and presumably persistent remission of their arthritis. After a follow-up time of 8 to 12 years, about 10% present a recurrent B27-associated oligoarthritis with some special clinical features. It is to be discussed whether this condition is a separate disease entity or still an abortive form of a well-known disease of the seronegative spondarthritis group.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3500826     DOI: 10.1007/BF02203389

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  9 in total

Review 1.  Axial spondyloarthritis: concept, construct, classification and implications for therapy.

Authors:  Philip C Robinson; Sjef van der Linden; Muhammad A Khan; William J Taylor
Journal:  Nat Rev Rheumatol       Date:  2020-12-23       Impact factor: 20.543

2.  Low grade radiographic sacroiliitis as prognostic factor in patients with undifferentiated spondyloarthritis fulfilling diagnostic criteria for ankylosing spondylitis throughout follow up.

Authors:  G Huerta-Sil; J C Casasola-Vargas; J D Londoño; R Rivas-Ruíz; J Chávez; C Pacheco-Tena; M H Cardiel; G Vargas-Alarcón; R Burgos-Vargas
Journal:  Ann Rheum Dis       Date:  2005-10-11       Impact factor: 19.103

Review 3.  Looking into the new ASAS classification criteria for axial spondyloarthritis through the other side of the glass.

Authors:  Nurullah Akkoc; Muhammad A Khan
Journal:  Curr Rheumatol Rep       Date:  2015-06       Impact factor: 4.592

Review 4.  Spontaneous, drug-induced, and drug-free remission in peripheral and axial spondyloarthritis.

Authors:  Denis Poddubnyy; Lianne S Gensler
Journal:  Best Pract Res Clin Rheumatol       Date:  2014-11-10       Impact factor: 4.098

Review 5.  Undifferentiated spondyloarthritis: a global perspective.

Authors:  Rubén Burgos-Vargas
Journal:  Curr Rheumatol Rep       Date:  2007-10       Impact factor: 4.592

6.  The assessment of the spondyloarthritis international society concept and criteria for the classification of axial spondyloarthritis and peripheral spondyloarthritis: A critical appraisal for the pediatric rheumatologist.

Authors:  Ruben Burgos-Vargas
Journal:  Pediatr Rheumatol Online J       Date:  2012-05-31       Impact factor: 3.054

Review 7.  Progression rate of ankylosing spondylitis in patients with undifferentiated spondyloarthritis: A systematic review and meta-analysis.

Authors:  Qing Xia; Dazhi Fan; Xiao Yang; Xiaona Li; Xu Zhang; Mengmeng Wang; Shengqian Xu; Faming Pan
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

8.  Percentage of progressors in imaging: can we ignore regressors?

Authors:  Alexandre Sepriano; Sofia Ramiro; Robert Landewé; Maxime Dougados; Desirée van der Heijde
Journal:  RMD Open       Date:  2019-02-26

9.  Factors associated with remission at 5-year follow-up in recent-onset axial spondyloarthritis: results from the DESIR cohort.

Authors:  Laura Pina Vegas; Emilie Sbidian; Daniel Wendling; Philippe Goupille; Salah Ferkal; Philippe Le Corvoisier; Bijan Ghaleh; Alain Luciani; Pascal Claudepierre
Journal:  Rheumatology (Oxford)       Date:  2022-04-11       Impact factor: 7.580

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.